Human protein tyrosine phosphatase 1B (PTP1B): from structure to clinical inhibitor perspectives
Phosphorylation is an essential process in biological events and is considered critical for
biological functions. In tissues, protein phosphorylation mainly occurs on tyrosine (Tyr) …
biological functions. In tissues, protein phosphorylation mainly occurs on tyrosine (Tyr) …
Thiazolidinediones as antidiabetic agents: A critical review
MJ Nanjan, M Mohammed, BRP Kumar… - Bioorganic …, 2018 - Elsevier
Abstract Thiazolidinediones (TZDs) or Glitazones are an important class of insulin
sensitizers used in the treatment of Type 2 diabetes mellitus (T2DM). TZDs were reported for …
sensitizers used in the treatment of Type 2 diabetes mellitus (T2DM). TZDs were reported for …
Recent applications of hydantoin and thiohydantoin in medicinal chemistry
SH Cho, SH Kim, D Shin - European journal of medicinal chemistry, 2019 - Elsevier
Abstract Hydantoin, imidazolidine-2, 4-dione, is a non-aromatic five-membered heterocycle,
which is considered a valuable, privileged scaffold in medicinal chemistry. The importance …
which is considered a valuable, privileged scaffold in medicinal chemistry. The importance …
The role of protein tyrosine phosphatase 1B (PTP1B) in the pathogenesis of type 2 diabetes mellitus and its complications
M Teimouri, H Hosseini, Z ArabSadeghabadi… - Journal of physiology …, 2022 - Springer
Insulin resistance, the most important characteristic of the type 2 diabetes mellitus (T2DM), is
mostly caused by impairment in the insulin receptor (IR) signal transduction pathway …
mostly caused by impairment in the insulin receptor (IR) signal transduction pathway …
Recent updates on development of protein-tyrosine phosphatase 1B inhibitors for treatment of diabetes, obesity and related disorders
S Singh, AS Grewal, R Grover, N Sharma, B Chopra… - Bioorganic …, 2022 - Elsevier
The aim of this review was to discuss an overview of type 2 diabetes; biology of PTP1B; role
of PTP1B in metabolic disorders; and recent updates in the development of PTP1B inhibitors …
of PTP1B in metabolic disorders; and recent updates in the development of PTP1B inhibitors …
Aldose reductase and protein tyrosine phosphatase 1B inhibitors as a promising therapeutic approach for diabetes mellitus
A Kousaxidis, A Petrou, V Lavrentaki… - European Journal of …, 2020 - Elsevier
Diabetes mellitus is a metabolic disease characterized by high blood glucose levels and
usually associated with several chronic pathologies. Aldose reductase and protein tyrosine …
usually associated with several chronic pathologies. Aldose reductase and protein tyrosine …
PTP1b inhibition, a promising approach for the treatment of diabetes type II
P Eleftheriou, A Geronikaki… - Current topics in medicinal …, 2019 - ingentaconnect.com
Background: Diabetes Mellitus (DM), is a metabolic disorder characterized by high blood
glucose levels. The main types of diabetes mellitus are Diabetes mellitus type I, Diabetes …
glucose levels. The main types of diabetes mellitus are Diabetes mellitus type I, Diabetes …
Design, synthesis, and anticancer activity of novel 4-thiazolidinone-phenylaminopyrimidine hybrids
Thiazolidinones and phenylaminopyrimidines are known as anticancer agents. Imatinib is
the pioneer phenylaminopyrimidine derivative kinase inhibitor, which is used for the …
the pioneer phenylaminopyrimidine derivative kinase inhibitor, which is used for the …
Protein tyrosine phosphatase 1B inhibitors: a molecular level legitimate approach for the management of diabetes mellitus
S Thareja, S Aggarwal, TR Bhardwaj… - Medicinal research …, 2012 - Wiley Online Library
Diabetes mellitus is a systemic disease responsible for morbidity in the western world and is
gradually becoming prevalent in developing countries too. The prevalence of diabetes is …
gradually becoming prevalent in developing countries too. The prevalence of diabetes is …
Diabetes reversal by inhibition of the low-molecular-weight tyrosine phosphatase
SM Stanford, AE Aleshin, V Zhang, RJ Ardecky… - Nature chemical …, 2017 - nature.com
Obesity-associated insulin resistance plays a central role in type 2 diabetes. As such,
tyrosine phosphatases that dephosphorylate the insulin receptor (IR) are potential …
tyrosine phosphatases that dephosphorylate the insulin receptor (IR) are potential …